Our mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently ruling this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.
Overview
Investors 4
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2022 | Fifty Years | fiftyyears.com |
| Verve Ventures | verve.vc | |
| Formic Ventures | formic.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 31, 2022 | Seed round | $2.55M |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 9, 2023 | MultiOmic Health Secures $6.2 Million | MMC Ventures was proud to participate in the round, alongside Hoxton Ventures, Ada Ventures, and Verve Ventures. Existing treatments for metabolic syndrome-related conditions merely reduce risk or delay onset of serious consequences such a... |
| May 5, 2023 | UK’s MultiOmic Health secures €5.7M for its AI-enabled precision drug discovery platform | London-based Multiomic Health, a company building an AI-enabled precision therapeutics discovery platform for metabolic syndrome diseases, announced on Thursday, May 4, that it has secured £5M (approximately €5.71M) in a Seed extension roun... |
| May 4, 2023 | MultiOmic Health Closes $6.2M Funding Round | MultiOmic Health, a London, UK-based artificial intelligence (AI)-enabled drug discovery company, raised $6.2M in funding. The round was led by Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve Ventures. The comp... |
| Multiomic Health | “AI-Enabled Precision Medicine for Metabolic Syndrome” |
Reviews 0
FAQ about Multiomic Health
When was Multiomic Health founded?
Multiomic Health was founded in 2021.
How much funding has Multiomic Health raised?
Multiomic Health has raised $8.83M in total across 2 funding rounds.
What funding rounds has Multiomic Health raised?
Parsers VC lists 2 funding rounds of Multiomic Health, among them a seed round of $2.55M on Jan 31, 2022.
Who has invested in Multiomic Health?
Parsers VC lists 4 investors of Multiomic Health, among them Fifty Years, Verve Ventures and Formic Ventures.
What has the press written about Multiomic Health?
Parsers VC has collected 5 articles mentioning Multiomic Health, among them “MultiOmic Health Secures $6.2 Million” (May 9, 2023) and “UK’s MultiOmic Health secures €5.7M for its AI-enabled precision drug discovery platform” (May 5, 2023).
Is Multiomic Health still active?
Yes, Multiomic Health is active; its latest activity on Parsers VC dates from Jul 26, 2024.